These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 30664155

  • 1. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
    Dong X, Wang F, Xue Y, Lin Z, Song W, Yang N, Li Q.
    Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
    [Abstract] [Full Text] [Related]

  • 2. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

  • 3. miR‑145‑5p reduces proliferation and migration of hepatocellular carcinoma by targeting KLF5.
    Liang H, Sun H, Yang J, Yi C.
    Mol Med Rep; 2018 Jun 05; 17(6):8332-8338. PubMed ID: 29658584
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L, Xu Q, Yang W, Liu Q, Tu K.
    J Exp Clin Cancer Res; 2018 Mar 06; 37(1):49. PubMed ID: 29510736
    [Abstract] [Full Text] [Related]

  • 5. Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma.
    Tian C, Yao S, Liu L, Ding Y, Ye Q, Dong X, Gao Y, Yang N, Li Q.
    Int J Mol Med; 2017 Jan 06; 39(1):47-56. PubMed ID: 27909734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma.
    Liu Z, Li W, Pang Y, Zhou Z, Liu S, Cheng K, Qin Q, Jia Y, Liu S.
    EBioMedicine; 2018 Dec 06; 38():57-68. PubMed ID: 30391496
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF, Zhang MF, Tian QH, Fu J, Yang X, Zhang CZ, Yang H.
    Mol Cancer; 2018 Aug 08; 17(1):117. PubMed ID: 30089483
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
    Ding W, Tan H, Li X, Zhang Y, Fang F, Tian Y, Li J, Pan X.
    Cancer Biomark; 2018 Aug 08; 22(3):427-434. PubMed ID: 29758928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y, Guo X, Xiong L, Yu L, Li Z, Guo Q, Li Z, Li B, Lin N.
    Mol Cancer; 2014 Nov 26; 13():253. PubMed ID: 25424347
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
    Wang X, Zeng J, Wang L, Zhang X, Liu Z, Zhang H, Dong J.
    Oncol Rep; 2017 Jul 26; 38(1):141-150. PubMed ID: 28586051
    [Abstract] [Full Text] [Related]

  • 14. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H, Peng Z, Tang H, Xie D, Jia Z, Zhong L, Zhao S, Ma Z, Gao Y, Zeng L, Luo R, Xie K.
    Oncogene; 2017 May 25; 36(21):2957-2968. PubMed ID: 28192402
    [Abstract] [Full Text] [Related]

  • 15. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 25; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA‑663b targets GAB2 to restrict cell proliferation and invasion in hepatocellular carcinoma.
    Guo L, Li B, Miao M, Yang J, Ji J.
    Mol Med Rep; 2019 Apr 25; 19(4):2913-2920. PubMed ID: 30720118
    [Abstract] [Full Text] [Related]

  • 17. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
    Shu G, Su H, Wang Z, Lai S, Wang Y, Liu X, Dai L, Bi Y, Chen W, Huang W, Zhou Z, He S, Dai H, Tang B.
    J Exp Clin Cancer Res; 2021 Jan 26; 40(1):45. PubMed ID: 33499874
    [Abstract] [Full Text] [Related]

  • 18. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z, Zhu J, Huang Y, Li W, Cheng H.
    Diagn Pathol; 2018 Nov 03; 13(1):85. PubMed ID: 30390677
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM, Xu JF, Fang F, Yang H, Yang LY.
    Tumour Biol; 2016 Aug 03; 37(8):10609-19. PubMed ID: 26861561
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J, Cheng J, Zeng Z, Wang Y, Li X, Xie Q, Jia J, Yan Y, Guo Z, Gao J, Yao M, Chen X, Lu F.
    Oncotarget; 2015 Dec 08; 6(39):42040-52. PubMed ID: 26547929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.